About Protein Labeling
Protein labeling is an essential and pivotal step in a protein research study, as the detection or purification of the protein of interest are possible through it. Labeling techniques result in the covalent attachment of different molecules, including fluorophores, biotin, radioactive isotopes, and reporter enzymes, to the target protein or nucleotide sequence. There is an availability of multiple labels in the market used for various applications. Therefore, the type of label and the labeling strategy used must be carefully considered and tailored for each application.
Technavio’s analysts forecast the global protein labeling market to grow at a CAGR of 10.47% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global protein labeling market for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sales of reagents, kits, and services utilized in proteomics experiments.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Protein Labeling Market 2017-2021
Technavio recognizes the following companies as the key players in the global protein labeling market: Merck KGaA, PerkinElmer, Promega, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: Eurogentec, F. Hoffman-La Roche, GE Healthcare, LI-COR, New England Biolabs, and SeraCare.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is emergence of post-translational modification monitoring. Enzymatic modification of proteins after protein synthesis is referred to as the process of post-translational modification (PTM). Monitoring these chemical alterations is revealing greater insights into real time functioning in the human body and is unlocking newer disease mechanisms. Protein functioning is being understood at an advanced level, and protein labeling techniques are facilitating an easier pathway to this.”
According to the report, one driver in the market is increasing advances in proteomics research. The study of proteins on a large scale and the techniques used for studying these proteins fall under the broad category of proteomics research. Proteins are majorly responsible for a large number of functions in the human body. Studying proteins improves the understanding of post-translational modifications and thus improves the knowledge of protein functioning, as these modifications directly influence the proteins' function. The field of proteomics has been greatly influenced by advances in molecular biology techniques such as next-generation sequencing and mass spectrometry, which enhanced the results in proteomics’ studies and are further improving the understanding of how the human body functions.
Further, the report states that one challenge in the market is high cost of equipment. The overall cost of equipment used in protein research is increasing at an alarming rate. Affordability is a major concern in developing regions, as emerging economies of the world have a large number of small and medium-scale laboratories, which have specific budgets and therefore prefer to partner with other institutions to carry out proteomic research. Traditionally large, complex, and expensive, mass spectrometers are often not found in individual labs, but instead in university core facilities. Researchers continue to send their samples to external laboratories for analysis or collaborate with proteomics specialists, who are readily available to process the samples for them.
Merck KGaA, PerkinElmer, Promega, Thermo Fisher Scientific, Eurogentec, F. Hoffman-La Roche, GE Healthcare, LI-COR, New England Biolabs, and SeraCare.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook